Ignite Creation Date:
2024-05-05 @ 11:40 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00103155
Status:
UNKNOWN
Last Update Posted:
2013-09-20
First Post:
2005-02-07
Brief Title:
Radiofrequency Ablation in Treating Patients Who Are Undergoing Surgery for Thyroid Cancer
Sponsor:
University of California San Francisco
Organization:
National Cancer Institute NCI
Study Overview
Official Title:
Radiofrequency Ablation for Low Risk Papillary Thyroid Cancer A Pilot Study
Status:
UNKNOWN
Status Verified Date:
2005-08
Last Known Status:
ACTIVE_NOT_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
RATIONALE Radiofrequency ablation uses a high-frequency electric current to kill tumor cells Ultrasound-guided radiofrequency ablation may be effective treatment for thyroid cancer
PURPOSE This phase I trial is studying the side effects of radiofrequency ablation in treating patients who are undergoing surgery for thyroid cancer
PURPOSE This phase I trial is studying the side effects of radiofrequency ablation in treating patients who are undergoing surgery for thyroid cancer
Detailed Description:
OBJECTIVES
Determine the frequency of complications associated with radiofrequency ablation RFA in patients with low-risk papillary thyroid cancer undergoing thyroidectomy
Determine the utility of RFA as a treatment option for these patients
OUTLINE This is a pilot study
An electrosurgical probe is placed by ultrasound guidance into the center of the thyroid tumor Patients undergo radiofrequency ablation directly to the tumor until the target temperature is reached for 5 minutes Patients then undergo standard thyroidectomy
NOTE Takes approximately 15-30 minutes to reach target temperature
After completion of study treatment patients are followed at day 1 between days 14-21 and then periodically as deemed necessary
PROJECTED ACCRUAL A total of 15-40 patients will be accrued for this study
Determine the frequency of complications associated with radiofrequency ablation RFA in patients with low-risk papillary thyroid cancer undergoing thyroidectomy
Determine the utility of RFA as a treatment option for these patients
OUTLINE This is a pilot study
An electrosurgical probe is placed by ultrasound guidance into the center of the thyroid tumor Patients undergo radiofrequency ablation directly to the tumor until the target temperature is reached for 5 minutes Patients then undergo standard thyroidectomy
NOTE Takes approximately 15-30 minutes to reach target temperature
After completion of study treatment patients are followed at day 1 between days 14-21 and then periodically as deemed necessary
PROJECTED ACCRUAL A total of 15-40 patients will be accrued for this study
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?:
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| UCSF-03202 | None | None | None |
| UCSF-H28355-23383-01 | None | None | None |